Role of calcitonin gene-related peptide in light-aversive behavior: Implications for migraine

Journal of Neuroscience

Volumn 29, Issue 27, 2009, Pages 8798-8804

  Recober, Ana ^a   Kuburas, Adisa ^a   Zhang, Zhongming ^a   Wemmie, John A ^a,b   Anderson, Michael G ^a   Russo, Andrew F ^a  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; OLCEGEPANT; RECEPTOR ACTIVITY MODIFYING PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; AVERSIVE BEHAVIOR; CONTROLLED STUDY; DISEASE PREDISPOSITION; EPIGENETICS; FEMALE; GENETIC MODEL; MALE; MIGRAINE; MOTOR ACTIVITY; MOUSE; NEUROBIOLOGY; NONHUMAN; PATHOLOGICAL ANATOMY; PHOTOPHOBIA; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; LIGHT; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MIGRAINE WITH AURA; MOTOR ACTIVITY; PHOTIC STIMULATION; PHOTOPHOBIA; RATS; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE;

EID: 67650502716     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1727-09.2009     Document Type: Article

References (41)

1. Amini A, Digre K, Couldwell WT (2006) Photophobia in a blind patient: an alternate visual pathway. Case report. J Neurosurg 105:765-768.
2. Arulmani U, Maassenvandenbrink A, Villalón CM, Saxena PR (2004) Calcitonin gene-related peptide and its role in migraine pathophysiology. Eur J Pharmacol 500:315-330.
3. Ashina M, Bendtsen L, Jensen R, Schifter S, Olesen J (2000) Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks. Pain 86:133-138.
4. Bahra A, May A, Goadsby PJ (2002) Cluster headache: a prospective clinical study with diagnostic implications. Neurology 58:354-361.
5. Benemei S, Nicoletti P, Capone JA, Geppetti P (2007) Pain pharmacology in migraine: focus on CGRP and CGRP receptors. Neurol Sci 28 [Suppl 2]:S89-S93.
6. Claustrat B, Brun J, Chiquet C, Chazot G, Borson-Chazot F (2004) Melatonin secretion is supersensitive to light in migraine. Cephalalgia 24:128-133.
7. Crawley J, Goodwin FK (1980) Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 13:167-170.
8. Doods H, Hallermayer G, Wu D, Entzeroth M, Rudolf K, Engel W, Eberlein W (2000) Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br J Pharmacol 129:420-423.
9. Drummond PD, Woodhouse A (1993) Painful stimulation of the forehead increases photophobia in migraine sufferers. Cephalalgia 13:321-324.
10. Gallai V, Alberti A, Gallai B, Coppola F, Floridi A, Sarchielli P (2003) Glutamate and nitric oxide pathway in chronic daily headache: evidence from cerebrospinal fluid. Cephalalgia 23:166-174.
11. Goadsby PJ, Edvinsson L (1993) The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 33:48-56.
12. Goadsby PJ, Edvinsson L (1994) Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain 117:427-434.
13. Goadsby PJ, Edvinsson L, Ekman R (1990) Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 28:183-187.
14. Goadsby PJ, Lipton RB, Ferrari MD (2002) Migraine-current understanding and treatment. N Engl J Med 346:257-270.
15. Hallett M, Evinger C, Jankovic J, Stacy M (2008) Update on blepharospasm: report from the BEBRF International Workshop. Neurology 71:1275-1282.
16. Hay DL, Poyner DR, Sexton PM (2006a) GPCR modulation by RAMPs. Pharmacol Ther 109:173-197.
17. Hay DL, Christopoulos G, Christopoulos A, Sexton PM (2006b) Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l-piperazinyl] carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl) methyl]-2-oxoethyl]-4- (1,4-dihydro-2-oxo-3(2 H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors - the role of receptor activity modifying protein 1. Mol Pharmacol 70:1984-1991.
18. Headache Classification Subcommittee of the International Headache Society (2004) The international classification of headache disorders: 2nd edition. Cephalalgia 24 [Suppl 1]:9-160.
19. Ho TW, Ferrari MD, Dodick DW, Galet V, Kost J, Fan X, Leibensperger H, Froman S, Assaid C, Lines C, Koppen H, Winner PK (2008) Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial. Lancet 372:2115-2123.
20. Irimia P, Cittadini E, Paemeleire K, Cohen AS, Goadsby PJ (2008) Unilateral photophobia or phonophobia in migraine compared with trigeminal autonomic cephalalgias. Cephalalgia 28:626-630.
21. Juhasz G, Zsombok T, Jakab B, Nemeth J, Szolcsanyi J, Bagdy G (2005) Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack. Cephalalgia 25:179-183.
22. Kowacs PA, Piovesan EJ, Werneck LC, Tatsui CE, Lange MC, Ribas LC, da Silva HP (2001) Influence of intense light stimulation on trigeminal and cervical pain perception thresholds. Cephalalgia 21:184-188.
23. Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J (2002) CGRP may play a causative role in migraine. Cephalalgia 22:54-61.
24. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF (2007) Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68:343-349.
25. Main A, Dowson A, Gross M (1997) Photophobia and phonophobia in migraineurs between attacks. Headache 37:492-495.
26. Main A, Vlachonikolis I, Dowson A (2000) The wavelength of light causing photophobia in migraine and tension-type headache between attacks. Headache 40:194-199.
27. Mallee JJ, Salvatore CA, LeBourdelles B, Oliver KR, Longmore J, Koblan KS, Kane SA (2002) Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists. J Biol Chem 277:14294-14298.
28. Marquez de Prado B, Hammond DL, Russo AF (2009) Genetic enhancement of calcitonin gene-related peptide-induced central sensitization to mechanical stimuli in mice. J Pain, in press.
29. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393:333-339.
30. Mulleners WM, Aurora SK, Chronicle EP, Stewart R, Gopal S, Koehler PJ (2001) Self-reported photophobic symptoms in migraineurs and controls are reliable and predict diagnostic category accurately. Headache 41:31-39.
31. Okamoto K, Thompson R, Tashiro A, Chang Z, Bereiter DA (2009) Bright light produces fos-positive neurons in caudal trigeminal brainstem. Neuroscience 160:858-864.
32. Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U, Pollentier S, Lesko LM (2004) Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 350:1104-1110.
33. Petersen KA, Lassen LH, Birk S, Lesko L, Olesen J (2005) BIBN4096BS antagonizes human alpha-calcitonin gene related peptide-induced headache and extracerebral artery dilatation. Clin Pharmacol Ther 77:202-213.
34. Sarchielli P, Alberti A, Floridi A, Gallai V (2001) Levels of nerve growth factor in cerebrospinal fluid of chronic daily headache patients. Neurology 57:132-134.
35. Sarchielli P, Pini LA, Coppola F, Rossi C, Baldi A, Mancini ML, Calabresi P (2007) Endocannabinoids in chronic migraine: CSF findings suggest a system failure. Neuropsychopharmacology 32:1384-1390.
36. Tfelt-Hansen P, Le H (2009) Calcitonin gene-related peptide in blood: is it increased in the external jugular vein during migraine and cluster headache? A review. J Headache Pain 10:137-143.
37. Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, Orban PC, Bock R, Klein R, Schütz G (1999) Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet 23:99-103.
38. Tvedskov JF, Lipka K, Ashina M, Iversen HK, Schifter S, Olesen J (2005) No increase of calcitonin gene-related peptide in jugular blood during migraine. Ann Neurol 58:561-568.
39. van Rossum D, Hanisch UK, Quirion R (1997) Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neurosci Biobehav Rev 21:649-678.
40. Zhang Z, Dickerson IM, Russo AF (2006) Calcitonin gene-related peptide receptor activation by receptor activity-modifying protein-1 gene transfer to vascular smooth muscle cells. Endocrinology 147:1932-1940.
41. Zhang Z, Winborn CS, Marquez de Prado B, Russo AF (2007) Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion. J Neurosci 27:2693-2703.